Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19
Researchers propose a treatment paradigm targeting leukotrienes, which play a key role in severe COVID-19 cases. The proposed combination of zileuton and montelukast could help reduce inflammation and prevent pulmonary edema.